Novel approaches to immune therapy and monitoring-Dr. Russell Pachynski -04/01/2014 - 8:30am

Event Information
Event Topic: 
Novel approaches to immune therapy and monitoring
Event Date: 
04/01/2014 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
Speaker Information
Event Speaker: 
Dr. Russell Pachynski
Event Speaker Title: 
Co-founder and Chief Scientific Officer
Event Speaker Company: 
CombImmune
Event Speaker Bio: 

As a translational researcher and clinical oncologist, Dr. Pachynski has extensive experience in early immunotherapy drug discovery and translating those efforts into real world approaches in bettering patient care. As a board certified medical oncologist, internist and instructor at Stanford Medical University Cancer Center, Dr. Pachynski completed his oncology fellowship at Stanford University. He received his Medical Doctorate from the University of Wisconsin-Madison Medical School and his B.S. in Biology from Stanford University. Dr. Pachynski consults and is an active scientific advisor for immunotherapy therapy pioneer Dendreon. As co-founder and Chief Scientific Officer, Dr. Pachynski leads CombImmune's research development and pre-clinical proof of concept studies.

Event Details
Cost: 
$0
Event Details: 

With the approval of Provenge and ipilumumab, immunotherapy anti-cancer agents have made major leaps in bettering patient outcomes. However, current strategies in combination immunotherapies looking at the right approaches, sequential treatment, patient monitoring, and surveillance will offer new insights in how specific therapies could be tailored for each individual cancer patient. Dr. Pachynski will discuss CombImmune's research efforts in novel mechanisms in leukocyte trafficking and monitoring of immune specific biomarkers.